Teva Challenges Shire's Adderall XR Patent
Israeli generics maker Teva Pharmaceuticals has initiated a challenge against the patent rights to U.K. drug maker Shire Pharmaceuticals Group PLC's blockbuster anti-hyperactivity treatment Adderall XR....To view the full article, register now.
Already a subscriber? Click here to view full article